Medical Decision Making

1981 - 2025

Bibliographic data for series maintained by SAGE Publications ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 42, issue 8, 2022

Filling the Gap Between Potential and Actual Usefulness of Electronic Health Record (EHR) Data as Patient-Level Evidence pp. 973-974

Stefano Conti

The Electronic Health Record as the Primary Data Source in a Pragmatic Trial: A Case Study pp. 975-984

Louise Russell, Qian Huang, Yuqing Lin, Laurie A. Norton, Jingsan Zhu, L. G. Iannotte, David A. Asch, Shivan J. Mehta, Monique S. Tanna, Andrea B. Troxel, Kevin G. Volpp and Lee R. Goldberg

Opportunities and Challenges When Using the Electronic Health Record for Practice-Integrated Patient-Facing Interventions: The e-Assist Colon Health Randomized Trial pp. 985-998

Jennifer Elston Lafata, Deirdre A. Shires, Yongyun Shin, Susan Flocke, Kenneth Resnicow, Morgan Johnson, Ellen Nixon, Xinxin Sun and Sarah Hawley

Creating a Real-World Linked Research Platform for Analyzing the Urgent and Emergency Care System pp. 999-1009

Suzanne Mason, Tony Stone, Richard Jacques, Jennifer Lewis, Rebecca Simpson, Maxine Kuczawski and Matthew Franklin

Local Instrumental Variable Methods to Address Confounding and Heterogeneity when Using Electronic Health Records: An Application to Emergency Surgery pp. 1010-1026

Silvia Moler-Zapata, Richard Grieve, David Lugo-Palacios, A. Hutchings, R. Silverwood, Luke Keele, Tommaso Kircheis, David Cromwell, Neil Smart, Robert Hinchliffe and Stephen O’Neill

Evaluating and Modeling Neighborhood Diversity and Health Using Electronic Health Records pp. 1027-1040

Jarrod E. Dalton, Elizabeth R. Pfoh, Neal V. Dawson, Lyla Mourany, Alissa Becerril, Douglas D. Gunzler, Kristen A. Berg, Douglas Einstadter, Nikolas I. Krieger and Adam T. Perzynski

Overscreening for Women’s Cancer: Time for Change pp. 1041-1044

Rani Marx

Rising to the De-escalation Challenge: Multilevel Change Needed to Align Clinical Practice with Cancer Screening Guidelines pp. 1045-1047

Marilyn M. Schapira and Katharine A. Rendle

Beyond Access: Prioritizing Equity during Discussions about Cancer Screening pp. 1048-1051

Ashley J. Housten

When Is Mass Prophylaxis Cost-Effective for Epidemic Control? A Comparison of Decision Approaches pp. 1052-1063

Giovanni S. P. Malloy and Margaret L. Brandeau

PaCAR: COVID-19 Pandemic Control Decision Making via Large-Scale Agent-Based Modeling and Deep Reinforcement Learning pp. 1064-1077

Xudong Guo, Peiyu Chen, Shihao Liang, Zengtao Jiao, Linfeng Li, Jun Yan, Yadong Huang, Yi Liu and Wenhui Fan

COVID-19 and Politically Motivated Reasoning pp. 1078-1086

Allegra Maguire, Emil Persson, Daniel Västfjäll and Gustav Tinghög

Volume 42, issue 7, 2022

When History and Heterogeneity Matter: A Tutorial on the Impact of Markov Model Specifications in the Context of Colorectal Cancer Screening pp. 845-860

Rachel M. Townsley, Priscille R. Koutouan, Maria E. Mayorga, Sarah D. Mills, Melinda M. Davis and Kristen Hasmiller Lich

Developing Economic Models for Assessing the Cost-Effectiveness of Multiple Diagnostic Tests: Methods and Applications pp. 861-871

Xuanqian Xie, Sean Tiggelaar, Jennifer Guo, Myra Wang, Stacey Vandersluis and Wendy J. Ungar

Metamodeling for Policy Simulations with Multivariate Outcomes pp. 872-884

Huaiyang Zhong, Margaret L. Brandeau, Golnaz Eftekhari Yazdi, Jianing Wang, Shayla Nolen, Liesl Hagan, William W. Thompson, Sabrina A. Assoumou, Benjamin P. Linas and Joshua A. Salomon

Trends in Author-Reported Cost-Effectiveness Thresholds in the United States from 1995 to 2018: Implications for Discount Rates pp. 885-892

Ankur Pandya, Mike Paulden, Jinyi Zhu, Tara A. Lavelle and James Hammitt

Approaches to Selecting “Time Zero†in External Control Arms with Multiple Potential Entry Points: A Simulation Study of 8 Approaches pp. 893-905

Anthony J. Hatswell, Kevin Deighton, Julia Thornton Snider, M. Alan Brookhart, Imi Faghmous and Anik R. Patel

Network Meta-analysis on Disconnected Evidence Networks When Only Aggregate Data Are Available: Modified Methods to Include Disconnected Trials and Single-Arm Studies while Minimizing Bias pp. 906-922

Howard Thom, Joy Leahy and Jeroen P. Jansen

A Machine-Learning Approach for Estimating Subgroup- and Individual-Level Treatment Effects: An Illustration Using the 65 Trial pp. 923-936

Zia Sadique, Richard Grieve, Karla Diaz-Ordaz, Paul Mouncey, Francois Lamontagne and Stephen O’Neill

Computable Phenotype of a Crohn’s Disease Natural History Model pp. 937-944

Jacob A. Kurowski, Jean-Paul Achkar, David Sugano, Alex Milinovich, Xinge Ji, Janine Bauman, Keyonna R. Griffin and Michael W. Kattan

Dynamic and Flexible Survival Models for Extrapolation of Relative Survival: A Case Study and Simulation Study pp. 945-955

Benjamin Kearns, Matt D. Stevenson, Kostas Triantafyllopoulos and Andrea Manca

Methods for Communicating the Impact of Parameter Uncertainty in a Multiple-Strategies Cost-Effectiveness Comparison pp. 956-968

Henri B. Wolff, Venetia Qendri, Natalia Kunst, Fernando Alarid-Escudero and Veerle M.H. Coupé

Volume 42, issue 6, 2022

Capitalizing on Opportunities to Integrate Theory and Practice in Medical Decision Making pp. 723-725

Alexander J. Rothman

The Framing Dilemma: Quantitative Information, Shared Decision Making, and Nudging pp. 726-728

Peter H. Schwartz

Numeracy and the Motivational Mind: The Power of Numeric Self-efficacy pp. 729-740

Ellen Peters and Brittany Shoots-Reinhard

Supporting Health and Medical Decision Making: Findings and Insights from Fuzzy-Trace Theory pp. 741-754

Valerie F. Reyna, Sarah Edelson, Bridget Hayes and David Garavito

Shared Decision Making in Health Care: Theoretical Perspectives for Why It Works and For Whom pp. 755-764

Ken Resnicow, Delwyn Catley, Kathy Goggin, Sarah Hawley and Geoffrey C. Williams

Linear Biases and Pandemic Communications pp. 765-775

Daniel Villanova

Medical Decision Style and COVID-19 Behavior pp. 776-782

Gustav Tinghög and Liam Strand

A Procedure for Eliciting Women’s Preferences for Breast Cancer Screening Frequency pp. 783-794

Emily Grayek, Yanran Yang, Baruch Fischhoff, Karen E. Schifferdecker, Steven Woloshin, Karla Kerlikowske, Diana L. Miglioretti and Anna N. A. Tosteson

Identifying a Single Optimal Integrated Cervical Cancer Prevention Policy in Norway: A Cost-Effectiveness Analysis pp. 795-807

Allison Portnoy, Kine Pedersen, Mari Nygård, Lill Trogstad, Jane J. Kim and Emily A. Burger

Clinical Decision Support with or without Shared Decision Making to Improve Preventive Cancer Care: A Cluster-Randomized Trial pp. 808-821

Thomas E. Elliott, Stephen E. Asche, Patrick J. O’Connor, Steven P. Dehmer, Heidi L. Ekstrom, Anjali R. Truitt, Ella A. Chrenka, Melissa L. Harry, Daniel M. Saman, Clayton I. Allen, Joseph A. Bianco, Laura A. Freitag and JoAnn M. Sperl-Hillen

An Objective Measure of Decisional Clarity to Assess Decision Aid Effectiveness in Situations with Equipoise: A Randomized Trial pp. 822-831

Jessica K. Witt

Noninferiority Margin Size and Acceptance of Trial Results: Contingent Valuation Survey of Clinician Preferences for Noninferior Mortality pp. 832-836

Sandra Pong, Robert A. Fowler, Nicholas Mitsakakis, Srinivas Murthy, Jeffrey M. Pernica, Elaine Gilfoyle, Asha Bowen, Patricia Fontela, Winnie Seto, Michelle Science, James S. Hutchison, Philippe Jouvet, Asgar Rishu and Nick Daneman

Nudging COVID-19 Vaccine Uptake by Changing the Default: A Randomized Controlled Trial pp. 837-841

Katya Tentori, Stefania Pighin, Giulia Giovanazzi, Andrea Grignolio, Benjamin Timberlake and Antonio Ferro

Volume 42, issue 5, 2022

Microsimulation Model Calibration with Approximate Bayesian Computation in R: A Tutorial pp. 557-570

Peter Shewmaker, Stavroula A. Chrysanthopoulou, Rowan Iskandar, Derek Lake and Earic Jutkowitz

A Game Theoretic Analysis of Competition Between Vaccine and Drug Companies during Disease Contraction and Recovery pp. 571-586

Kjell Hausken and Mthuli Ncube

Can Machine Learning from Real-World Data Support Drug Treatment Decisions? A Prediction Modeling Case for Direct Oral Anticoagulants pp. 587-598

Andreas D. Meid, Lucas Wirbka, Andreas Groll and Walter E. Haefeli

Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge pp. 599-611

Michelle Tew, Michael Willis, Christian Asseburg, Hayley Bennett, Alan Brennan, Talitha Feenstra, James Gahn, Alastair Gray, Laura Heathcote, William H. Herman, Deanna Isaman, Shihchen Kuo, Mark Lamotte, José Leal, Phil McEwan, Andreas Nilsson, Andrew J. Palmer, Rishi Patel, Daniel Pollard, Mafalda Ramos, Fabian Sailer, Wendelin Schramm, Hui Shao, Lizheng Shi, Lei Si, Harry J. Smolen, Chloe Thomas, An Tran-Duy, Chunting Yang, Wen Ye, Xueting Yu, Ping Zhang and Philip Clarke

An Efficient Method for Computing Expected Value of Sample Information for Survival Data from an Ongoing Trial pp. 612-625

Mathyn Vervaart, Mark Strong, Karl P. Claxton, Nicky J. Welton, Torbjørn Wisløff and Eline Aas

Calculating Expected Value of Sample Information Adjusting for Imperfect Implementation pp. 626-636

Anna Heath

A Revised Framework to Evaluate the Consistency Assumption Globally in a Network of Interventions pp. 637-648

Loukia M. Spineli

Prioritizing Research in an Era of Personalized Medicine: The Potential Value of Unexplained Heterogeneity pp. 649-660

Anna Heath and Petros Pechlivanoglou

Uncertainty and the Value of Information in Risk Prediction Modeling pp. 661-671

Mohsen Sadatsafavi, Tae Yoon Lee and Paul Gustafson

Estimating Value-Based Price and Quantifying Uncertainty around It in Health Technology Assessment: Frequentist and Bayesian Approaches pp. 672-683

Yasuhiro Hagiwara and Takeru Shiroiwa

The Use of Expert Elicitation among Computational Modeling Studies in Health Research: A Systematic Review pp. 684-703

Christopher J. Cadham, Marie Knoll, Luz María Sánchez-Romero, K. Michael Cummings, Clifford E. Douglas, Alex Liber, David Mendez, Rafael Meza, Ritesh Mistry, Aylin Sertkaya, Nargiz Travis and David T. Levy

A Systematic Literature Review of Health Utility Values in Breast Cancer pp. 704-719

Manraj N. Kaur, Jiajun Yan, Anne F. Klassen, Justin P. David, Dilshan Pieris, Manraj Sharma, Louise Bordeleau and Feng Xie

Volume 42, issue 4, 2022

Optimal Sample Size Calculation for Clinical Research under a Budget Constraint pp. 417-418

Afschin Gandjour

Author Response to “Optimal Sample Size Calculation for Clinical Research under a Budget Constraint†pp. 419-420

Michael Fairley, Lauren E. Cipriano and Jeremy D. Goldhaber-Fiebert

Generating, Presenting, and Interpreting Cost-Effectiveness Results in the Context of Uncertainty: A Tutorial for Deeper Knowledge and Better Practice pp. 421-435

Joke Bilcke and Philippe Beutels

Assessing Interventions That Prevent Multiple Infectious Diseases: Simple Methods for Multidisease Modeling pp. 436-449

Anneke L. Claypool, Jeremy D. Goldhaber-Fiebert and Margaret L. Brandeau

Personalization of Medical Treatment Decisions: Simplifying Complex Models while Maintaining Patient Health Outcomes pp. 450-460

Christopher Weyant and Margaret L. Brandeau

Expected Value of Sample Information to Guide the Design of Group Sequential Clinical Trials pp. 461-473

Laura Flight, Steven Julious, Alan Brennan and Susan Todd

A Value-of-Information Framework for Personalizing the Timing of Surveillance Testing pp. 474-486

Aasthaa Bansal, Patrick J. Heagerty, Lurdes Y. T. Inoue, David L. Veenstra, Charles J. Wolock and Anirban Basu

Model-Based ROC Curve: Examining the Effect of Case Mix and Model Calibration on the ROC Plot pp. 487-499

Mohsen Sadatsafavi, Paramita Saha-Chaudhuri and John Petkau

Recalibration Methods for Improved Clinical Utility of Risk Scores pp. 500-512

Anu Mishra, Robyn L. McClelland, Lurdes Y. T. Inoue and Kathleen F. Kerr

Risk Stratification in Cost-Effectiveness Analyses of Cancer Screening: Intervention Eligibility, Strategy Choice, and Optimality pp. 513-523

James F. O’Mahony

Evaluating Risk-Stratified HPV Catch-up Vaccination Strategies: Should We Go beyond Age 26? pp. 524-537

Fan Wang, Kristen N. Jozkowski and Shengfan Zhang

Quantifying the Impact of Capacity Constraints in Economic Evaluations: An Application in Precision Medicine pp. 538-553

Stuart J. Wright, William G. Newman and Katherine Payne

Abstracts 2021 Virtual Annual Meeting for the Society of Medical Decision Making, October 18-20, 2021 pp. NP1-NP239

N/a

Volume 42, issue 3, 2022

Toward Transparent Demographic Analyses: Statement on the Use and Reporting of Classification Variables Presented as Measuring Individual Characteristics Such as Race, Ethnicity, Indigeneity, National Origin, Gender, Sexual Orientation, or Socioeconomic Status pp. 277-279

Brian J. Zikmund-Fisher

Medical Decision Making and MDM Policy & Practice Reviewers, 2021 pp. 280-282

N/a

Doctors’ Attitudes to Patient Question Asking, Patient-Generated Question Lists, and Question Prompt Lists: A Qualitative Study pp. 283-292

Marguerite Clare Tracy, Danielle Maree Muscat, Heather L. Shepherd and Lyndal Jane Trevena

Comparison of Diagnostic Recommendations from Individual Physicians versus the Collective Intelligence of Multiple Physicians in Ambulatory Cases Referred for Specialist Consultation pp. 293-302

Elaine C. Khoong, Sarah S. Nouri, Delphine S. Tuot, Shantanu Nundy, Valy Fontil and Urmimala Sarkar

Physicians under Pressure: Evidence from Antibiotics Prescribing in England pp. 303-312

Thomas Allen, Dorte Gyrd-Hansen, Søren Kristensen, Anne Sophie Oxholm, Line Bjørnskov Pedersen and Mario Pezzino

Key Factors in Decision Making for ECLS: A Binational Factorial Survey pp. 313-325

Daniel Drewniak, Giovanna Brandi, Philipp Karl Buehler, Peter Steiger, Niels Hagenbuch, Sabine Stamm-Balderjahn, Liane Schenk, Ana Rosca and Tanja Krones

Perceived Social Norms Guide Health Care Decisions for Oneself and Others: A Cross-Sectional Experiment in a US Online Panel pp. 326-340

JoNell Strough, Eric R. Stone, Andrew M. Parker and Wändi Bruine de Bruin

Don’t Throw Your Heart Away: Increased Transparency of Donor Utilization Practices in Transplant Center Report Cards Alters How Center Performance Is Evaluated pp. 341-351

Alison E. Butler and Gretchen B. Chapman

Relationships among Antecedents, Processes, and Outcomes for Shared Decision Making: A Cross-Sectional Survey of Patients with Lumbar Degenerative Disease pp. 352-363

Chia-Hsien Chen, Hsin-Yi Chuang, Yen Lee, Glyn Elwyn, Wen-Hsuan Hou and Ken N. Kuo

Preparing Patients with Early Stage Prostate Cancer to Participate in Clinical Appointments Using a Shared Decision Making Training Video pp. 364-374

Karen Scherr, Rebecca K. Delaney, Peter Ubel, Valerie C. Kahn, Daniel Hamstra, John T. Wei and Angela Fagerlin

Fostering Patient Choice Awareness and Presenting Treatment Options Neutrally: A Randomized Trial to Assess the Effect on Perceived Room for Involvement in Decision Making pp. 375-386

Arwen H. Pieterse, Kim Brandes, Jessica de Graaf, Joyce E. de Boer, Nanon H. M. Labrie, Anouk Knops, Cornelia F. Allaart, Johanna E. A. Portielje, Willem Jan W. Bos and Anne M. Stiggelbout

The Impact of 4 Risk Communication Interventions on Cancer Screening Preferences and Knowledge pp. 387-397

K. D. Valentine, Pete Wegier, Victoria A. Shaffer and Laura D. Scherer

Effect of Superstitious Beliefs and Risk Intuitions on Genetic Test Decisions pp. 398-403

Kristen E. Riley, Andrew L. Sussman, Elizabeth Schofield, Dolores D. Guest, Yvonne T. Dailey, Matthew R. Schwartz, David B. Buller, Keith Hunley, Kimberly A. Kaphingst, Marianne Berwick and Jennifer L. Hay

Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial pp. 404-414

Christopher E. Knoepke, Erin L. Chaussee, Daniel D. Matlock, Jocelyn S. Thompson, Colleen K. McIlvennan, Amrut V. Ambardekar, Elisabeth M. Schaffer, Prateeti Khazanie, Laura Scherer, Robert M. Arnold and Larry A. Allen

Volume 42, issue 2, 2022

Measuring What Matters: Little Evidence Supporting the Content Validity of EQ-5D in People with Duchenne Muscular Dystrophy and Their Caregivers pp. 139-140

Philip A. Powell, Jill Carlton, Donna Rowen, John Brazier, Karen Facey, Klair Bayley, Fleur Chandler, Josie Godfrey and Emily Crossley

Authors’ Response to Comment on “Assessing the Appropriateness of the EQ-5D for Duchenne Muscular Dystrophy: A Patient-Centered Study†pp. 141-142

Norah L. Crossnohere, Ryan Fischer, Andrew Lloyd, Lisa A. Prosser and John F. P. Bridges

Simulating Study Data to Support Expected Value of Sample Information Calculations: A Tutorial pp. 143-155

Anna Heath, Mark Strong, David Glynn, Natalia Kunst, Nicky J. Welton and Jeremy D. Goldhaber-Fiebert

Augmented Inverse Probability Weighting and the Double Robustness Property pp. 156-167

Christoph F. Kurz

Multilevel and Quasi Monte Carlo Methods for the Calculation of the Expected Value of Partial Perfect Information pp. 168-181

Wei Fang, Zhenru Wang, Michael B. Giles, Chris H. Jackson, Nicky J. Welton, Christophe Andrieu and Howard Thom

Reference Case Methods for Expert Elicitation in Health Care Decision Making pp. 182-193

Laura Bojke, Marta O. Soares, Karl Claxton, Abigail Colson, Aimée Fox, Chris Jackson, Dina Jankovic, Alec Morton, Linda D. Sharples and Andrea Taylor

Estimating Treatment-Switching Bias in a Randomized Clinical Trial of Ovarian Cancer Treatment: Combining Causal Inference with Decision-Analytic Modeling pp. 194-207

Felicitas Kuehne, Ursula Rochau, Noman Paracha, Jennifer M. Yeh, Eduardo Sabate and Uwe Siebert

Testing for a Sweet Spot in Randomized Trials pp. 208-216

Donald A. Redelmeier, Deva Thiruchelvam and Robert J. Tibshirani

Reducing the Prevalence of Alcohol-Exposed Pregnancies in the United States: A Simulation Modeling Study pp. 217-227

Reza Yaesoubi, Maya Mahin, Geoffrey Martin, A. David Paltiel and Mona Sharifi

Improving the Estimation of Subgroup Effects for Clinical Trial Participants with Multimorbidity by Incorporating Drug Class-Level Information in Bayesian Hierarchical Models: A Simulation Study pp. 228-240

Laurie J. Hannigan, David M. Phillippo, Peter Hanlon, Laura Moss, Elaine W. Butterly, Neil Hawkins, Sofia Dias, Nicky J. Welton and David A. McAllister

Development and Validation of a Discrete Event Simulation Model to Evaluate the Cardiovascular Impact of Population Policies for Obesity pp. 241-254

Arantzazu Arrospide, Oliver Ibarrondo, Iván Castilla, Igor Larrañaga and Javier Mar

Defensive Medicine Practices: Scale Development and Validation pp. 255-261

Özgün Ünal and Mahmut Akbolat

The Application of Multicriteria Decision Analysis Methods in Health Care: A Literature Review pp. 262-274

Ilyas Khan, Liliane Pintelon and Harry Martin

Corrigendum pp. NP1-NP1

N/a

Volume 42, issue 1, 2022

Translating Evidence Updates to International Standards: Is More Certainty Needed for International Standards on Decision Aids? pp. 3-7

Stacey L. Sheridan

Partial Personalization of Medical Treatment Decisions: Adverse Effects and Possible Solutions pp. 8-16

Christopher Weyant and Margaret L. Brandeau

Program Evaluation of Population- and System-Level Policies: Evidence for Decision Making pp. 17-27

Simon Walker, Aimee Fox, James Altunkaya, Tim Colbourn, Mike Drummond, Susan Griffin, Nils Gutacker, Paul Revill and Mark Sculpher

Choosing a Metamodel of a Simulation Model for Uncertainty Quantification pp. 28-42

Tiago M. de Carvalho, Joost van Rosmalen, Harold B. Wolff, Hendrik Koffijberg and Veerle M. H. Coupé

A Simple Method for Simulating Dementia Onset and Death within an Existing Demographic Model pp. 43-50

Carolyn M. Rutter, Ifeanyi Edochie, Esther M. Friedman, Mary E. Slaughter and Margaret M. Weden

Medicare’s Hospital Value-Based Purchasing Program Values Quality over QALYs pp. 51-59

Edward Norton, Jun Li, Anup Das, Andrew M. Ryan and Lena M. Chen

Randomized Controlled Trial of Paper-Based at a Hospital versus Continual Electronic Patient-Reported Outcomes at Home for Metastatic Cancer Patients: Does Electronic Measurement at Home Detect Patients’ Health Status in Greater Detail? pp. 60-67

Takeru Shiroiwa, Yasuhiro Hagiwara, Naruto Taira, Takuya Kawahara, Keiko Konomura, Tetsuya Iwamoto, Shinichi Noto, Takashi Fukuda and Kojiro Shimozuma

One Size Does Not Fit All: Financial Incentives Needed to Change Physical Exercise Levels for Different Groups pp. 68-79

Alberto Longo, Eileen Mitchell, Anil Markandya and Ibon Galarraga

Spillover Effects of Mental Health Disorders on Family Members’ Health-Related Quality of Life: Evidence from a US Sample pp. 80-93

Donghoon Lee, Yeonil Kim and Beth Devine

Effect of Having, but Not Consulting, a Computerized Diagnostic Aid pp. 94-104

Mark V. Pezzo, Brenton E. D. Nash, Pierre Vieux and Hannah W. Foster-Grammer

Using Standardized Videos to Examine the Validity of the Shared Decision Making Process Scale: Results of a Randomized Online Experiment pp. 105-113

K. D. Valentine, Brittney Mancini, Ha Vo, Suzanne Brodney, Carol Cosenza, Michael J. Barry and Karen R. Sepucha

The Multifocal Approach to Sharing in Shared Decision Making: A Critical Appraisal of the MAPPIN’SDM pp. 114-124

David Forner, Christopher W. Noel, Laura Boland, Arwen H. Pieterse, Cornelia M. Borkhoff and Paul Hong

The Influence of Patient and Provider Religious and Spiritual Beliefs on Treatment Decision Making in the Cancer Care Context pp. 125-134

Elizabeth Palmer Kelly, Brian Myers, Brent Henderson, Petra Sprik, Kelsey B. White and Timothy M. Pawlik

CORRIGENDUM to “Opportunities, Pitfalls, and Alternatives in Adapting Electronic Health Records for Health Services Research†pp. 135-135

N/a

Corrigendum pp. 136-136

N/a

Erratum pp. NP1-NP1

N/a